PDCD1 and cancer: Our study found that both serum carcinoembryonic antigen levels and tumor metastasis sites were correlated with the cancer response to PD-1 inhibitor treatment and could be integrated with imaging features to generate a radiomics model, and the radiomics model exhibited a good diagnostic performance and clinical application.